Home

Exchange-Traded Funds

>

First Trust NYSE Arca Biotechnology ETF


Holdings (as at 2026-09-18)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.97%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2026-09-18)
Security Name % of Net Assets
Halozyme Therapeutics, Inc. 4.57%
NeoGenomics, Inc. 4.37%
Natera, Inc. 4.24%
Illumina, Inc. 3.90%
Repligen Corporation 3.80%
Corcept Therapeutics Inc. 3.72%
Genmab A/S (ADR) 3.71%
Regeneron Pharmaceuticals, Inc. 3.66%
BeOne Medicines Ltd. (ADR) 3.64%
Gilead Sciences, Inc. 3.58%
argenx SE (ADR) 3.50%
Biogen Inc. 3.35%
BioMarin Pharmaceutical Inc. 3.35%
Incyte Corporation 3.33%
Amgen Inc. 3.29%
Sarepta Therapeutics, Inc. 3.29%
BioNTech SE (ADR) 3.25%
Vertex Pharmaceuticals Incorporated 3.25%
Exelixis, Inc. 3.20%
Bruker Corporation 3.17%
Bio-Techne Corporation 3.15%
ADMA Biologics, Inc. 3.11%
TG Therapeutics, Inc. 3.09%
Madrigal Pharmaceuticals, Inc. 3.07%
United Therapeutics Corporation 2.80%
Axsome Therapeutics, Inc. 2.75%
Alkermes Plc 2.59%
Neurocrine Biosciences, Inc. 2.56%
Alnylam Pharmaceuticals, Inc. 2.48%
Veracyte, Inc. 2.16%
Dreyfus Government Cash Management (Institutional Shares) 0.09%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.

FT Portfolios Canada Co.
40 King Street West, Suite 5102, Scotia Plaza, Box 312, Toronto, ON M5H 3Y2 1-877-622-5552
Copyright ©2026 FT Portfolios Canada Co. All Rights Reserved.
  Important Legal Information | Terms of Use | Privacy Policy | Cookie Policy